3176 results for «372»
3176 results
Most impactful trials in structural heart disease 2024/2025
30 Sep 2025 – From PCR Gulf Valves 2025
Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...
Second valve strategies with SAPIEN 3 Ultra RESILIA
30 Sep 2025 – From PCR Gulf Valves 2025
Gain key insights into managing second valve interventions with the SAPIEN 3 Ultra RESILIA system.
This session helps you anticipate and address complex scenarios such as mitral valve-in-valve, TAV-in-SAV, and valve-in-valve-in-valve procedures. Learn from expert case discussions that explore procedural strategies, technical challenges, and best practices to...
Abstracts and challenging clinical cases
30 Sep 2025 – From PCR Gulf Valves 2025
Engage with a dynamic collection of abstracts and challenging clinical cases that highlight the latest advances and investigative studies in interventional cardiology. Topics include innovative approaches to aortic stenosis management, AI-powered procedural planning, hemodynamic insights beyond traditional imaging, and complex valve interventions, providing a comprehensive overview...
3D echocardiography for structural procedures
30 Sep 2025 – From PCR Gulf Valves 2025
This session provides an in-depth understanding of three-dimensional (3D) echocardiography in structural heart procedures. Learn how to optimize 3D echocardiographic imaging for various valve interventions, including mitral valve procedures, and gain practical skills through hands-on training to enhance procedural guidance and outcomes.
Complex femoral access for TAVI in bicuspid aortic stenosis - LIVE Case
30 Sep 2025 – From PCR Gulf Valves 2025
A 74-year-old male with a history of multiple PCIs, peripheral arterial disease, and type 2 DM presented with symptomatic bicuspid aortic stenosis and preserved LV function.
A 26 mm Myval valve was implanted via right femoral artery access, with right radial secondary access, following predilatation with a...
Echocardiography for mitral valvuloplasty ballooning
30 Sep 2025 – From PCR Gulf Valves 2025
Enhance your expertise in echocardiography assessment and intraprocedural guidance for mitral valvuloplasty ballooning. This session focuses on evaluating mitral stenosis, distinguishing suitable from non-suitable candidates, and offers practical, hands-on experience to optimize procedural outcomes using echocardiographic techniques.
PCR Gulf Valves 2025 Closing Ceremony
30 Sep 2025 – From PCR Gulf Valves 2025
Join the PCR Gulf Valves 2025 Closing Ceremony to reflect on the advancements and highlights of this year’s sessions dedicated to valvular interventions. This event marks the culmination of comprehensive educational activities, fostering collaboration and innovation in valvular heart disease management within the Gulf region.
PCR Gulf Valves 2025 Opening Ceremony
29 Sep 2025 – From PCR Gulf Valves 2025
Join us for the PCR Gulf Valves 2025 Opening Ceremony, marking the commencement of an exceptional congress dedicated to advances in structural heart interventions. This session sets the stage for the latest innovations and expert discussions that will shape the future of valve therapies in the...
Left main bifurcation - LIVE Case
30 Jan 2026 – From SASCI-AfricaPCR
Join this session if you want to understand and optimise treatment strategies for LM bifurcation lesions, specifically: Understanding LM bifurcation anatomy and physiology, choosing the best stent strategy, optimising stent deployment and results.
LIVE Case from Groote Schuur Hospital Cape Town
Calcified lesions - LIVE Case
30 Jan 2026 – From SASCI-AfricaPCR
Watch this session if you want to understand the challenges and risks when treating calcified lesions, to learn how to accurately assess coronary calcification, to learn how to utilise the tools available for treating calcified lesions.
LIVE Case from Groote Schuur Hospital Cape Town
Design that delivers the future of TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
This session presents the future of TAVI valve design, emphasizing supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches tailored for long-term patient management.
Coronary sinus reducer for microvascular angina
28 Feb 2020
A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial
26 Oct 2023
Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial
Author
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
